NCT04865679View on ClinicalTrials.gov

Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Symptomatic NeuromaAmputationChronic Nerve Pain
Interventions
DEVICE

Axoguard Nerve Cap®

Entubulation of the nerve stump into the Axoguard Nerve Cap® following surgical excision of symptomatic neuroma

Trial Locations (2)

79430

Texas Tech University, Health Science Center, Lubbock

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Axogen Corporation
All Listed Sponsors
lead

Axogen Corporation

INDUSTRY